In a new report, “Powering Vaccine R&D: Opportunities for Transformation,” the Sabin-Aspen Vaccine Science & Policy Group uses lessons learned from the rapid development of COVID-19 vaccines to explore opportunities to overhaul vaccine R&D practices to better prepare for the next pandemic, to make strides against diseases currently without vaccines, and to establish next-generation vaccines that offer meaningful improvements.
The Influenzer Initiative’s online game earns the STEM.org Authenticated™ Educational Product Trustmark
Major General (Ret) Philip King Russell, physician, scientist, soldier, family man, and global health advocate who dedicated his life to protecting humans from infectious disease through vaccines, died peacefully on January 21, 2021, just a few months after being diagnosed with cancer and one week before his 89th birthday. Phil’s proudest achievement and greatest joy was his large and ever-expanding family, and after living in the Washington, DC area for more than 40 years, Phil and his wife of 65 years, Constance Rice Russell, moved to the Denver area in 2014 to be closer to their family. Phil passed his final days with Connie and his three children (Katherine Russell Kingsbery, Ellen King Russell Herting and Richard Webster Russell) by his side. He is also survived by six grandchildren, Russell Everette Kingsbery, Kelsey Louise Kingsbery, William Webster Kingsbery, Avery Grace Russell, Peyton Christine Russell, Taylor King Russell and three great grandchildren.
The Sabin Vaccine Institute (Sabin) announced today that it has awarded grants to research teams in four countries to explore the social drivers of COVID-19 misinformation, and its impact on routine immunization acceptance and the acceptance of a COVID-19 vaccine.
The Sabin Vaccine Institute (Sabin) is pleased to announce the Board of Trustees has unanimously elected Regina Rabinovich, MD, MPH, as board chair and elected two new trustees, Dr. Norman Baylor and Dr. JoAnn Suzich, to strengthen the organization’s leadership in global immunization and vaccine research and development.
As COVID-19 vaccine developers generate clinical evidence of safety and effectiveness needed for vaccine approval, this project will help prepare for the efficient and equitable distribution of vaccines globally by ensuring that national immunization programs have the resources and health systems in place to achieve sustainable global protection from COVID-19 by 2022 and strengthen capacity for vaccination across the life span.